Logos Global Management LP Olema Pharmaceuticals, Inc. Transaction History
Logos Global Management LP
- $775 Million
- Q2 2025
A detailed history of Logos Global Management LP transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 3,208,875 shares of OLMA stock, worth $17 Million. This represents 1.76% of its overall portfolio holdings.
Number of Shares
3,208,875
Previous 3,208,875
-0.0%
Holding current value
$17 Million
Previous $12.1 Million
13.29%
% of portfolio
1.76%
Previous 2.35%
Shares
3 transactions
Others Institutions Holding OLMA
# of Institutions
123Shares Held
68.7MCall Options Held
0Put Options Held
31.4K-
Bain Capital Life Sciences Investors, LLC Boston, MA6.84MShares$36.3 Million8.75% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.76MShares$35.9 Million1.35% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$28.1 Million0.89% of portfolio
-
Black Rock Inc. New York, NY4MShares$21.2 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.51MShares$18.6 Million0.08% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $215M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...